Analyst Price Targets — HSIC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 19, 2026 12:14 pm | David Larsen | BTIG | $110.00 | $90.62 | TheFly | Henry Schein price target raised to $110 from $100 at BTIG |
| August 6, 2026 9:32 am | — | Barclays | $100.00 | $89.59 | TheFly | Henry Schein price target raised to $100 from $86 at Barclays |
| August 5, 2026 11:39 am | Michael Petusky | Barrington | $104.00 | $89.11 | TheFly | Henry Schein price target raised to $104 from $97 at Barrington |
| August 5, 2026 11:19 am | Kevin Caliendo | UBS | $94.00 | $89.11 | TheFly | Henry Schein price target raised to $94 from $89 at UBS |
| August 5, 2026 11:05 am | — | Stifel Nicolaus | $95.00 | $89.11 | TheFly | Henry Schein price target raised to $95 from $84 at Stifel |
| July 28, 2026 12:17 pm | — | UBS | $89.00 | $85.88 | TheFly | Henry Schein price target raised to $89 from $85 at UBS |
| July 8, 2026 8:25 pm | Vik Chopra | BMO Capital | $85.00 | $83.22 | TheFly | Henry Schein initiated with a Market Perform at BMO Capital |
| June 11, 2026 9:13 am | — | BTIG | $100.00 | $78.85 | TheFly | BTIG upgrades Henry Schein to Buy on 'healthy' dental markets |
| May 6, 2026 1:32 pm | Kevin Caliendo | UBS | $85.00 | $74.35 | TheFly | Henry Schein price target lowered to $85 from $87 at UBS |
| May 6, 2026 11:47 am | — | Mizuho Securities | $82.00 | $74.37 | TheFly | Henry Schein price target lowered to $82 from $88 at Mizuho |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for HSIC

Bank of New York Mellon Corp purchased a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 505,999 shares of the company's stock, valued at approximately $42,261,000. Bank of New York

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value investors?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.

Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
